Altria Group reported robust Q4 earnings, driven by NJOY's alternative products growth. Click here to see why MO stock is a ...

The healthcare industry is poised for growth driven by aging populations, technological advancements, and increased ...

Medical device company Boston Scientific (NYSE:BSX) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 22.4% year on year to $4.56 billion. Guidance for next ...

Foresight's Growth VCTs invested an initial £4.5m in HSL in 2015, which supported the appointment of CEO Dominic Walsh.

A Belfast-based medical products distributor has been sold to a Scandinavian trade buyer in a deal which provides an exit for private equity and infrastructure investment manager Foresight Group.

AbbVie, Vertex Pharmaceuticals, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to ...

The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in ...

Ametek stands on strong financial footing, in our view. It maintains a wide array of loans at varying maturities from a diverse lending base. 2005 marked the last year Ametek’s net debt/EBITDA ratio ...

Minnetronix Medical — one of 500 medical device companies based in Minnesota — isn’t expecting a major impact from the Trump ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

For startups, this rapid expansion presents an opportunity to innovate and capture a share of the market by developing ...

Teladoc Health will buy at-home testing company Catapult Health for $65 million in cash as it aims to grow its business ...